Perez-Brumer, Amaya G

Published purpose

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s Pan-Canadian STBBI Framework for Action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research. • Research that focuses on key populations identified by Canada’s Pan-Canadian STBBI Framework for Action is highly encouraged. • This priority announcement will fund one (1) early career investigator for a total of three (3) years. • Information on the strategic directions of the CIHR HIV/AIDS and STBBI Research Initiative can be found in the CIHR HIV/AIDS Research Initiative: Strategic Plan (2015-2020).